Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

U.K. approves phase I/II trial of topical Melanotan

Jan. 27, 2005

No Comments

BioTie inlicenses BKT-104

Jan. 26, 2005

No Comments

Pfizer researchers describe androgen receptor antagonists

Jan. 21, 2005

No Comments

TB4 to be studied in phase II trial for venous stasis ulcers

Jan. 20, 2005

No Comments

Endpoint not met in phase IIb study of Fibrostat for hypertrophic scars

Jan. 20, 2005

No Comments

Corgentech files IND to begin phase I/II trial of NF-kappaB Decoy in eczema

Jan. 18, 2005

No Comments

Xoma restructures Raptiva agreement with Genentech

Jan. 17, 2005

No Comments

Phase II planned for PTH (1-34) after merger

Jan. 17, 2005

No Comments

Positive data for oral Rambazole in psoriasis

Jan. 14, 2005

No Comments

CB-03-01: a novel, selective androgen antagonist for topical use

Jan. 13, 2005

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

U.K. approves phase I/II trial of topical Melanotan

BioTie inlicenses BKT-104

Pfizer researchers describe androgen receptor antagonists

TB4 to be studied in phase II trial for venous stasis ulcers

Endpoint not met in phase IIb study of Fibrostat for hypertrophic scars

Corgentech files IND to begin phase I/II trial of NF-kappaB Decoy in eczema

Xoma restructures Raptiva agreement with Genentech

Phase II planned for PTH (1-34) after merger

Positive data for oral Rambazole in psoriasis

CB-03-01: a novel, selective androgen antagonist for topical use

Today's news in brief

Today's news in brief

Abbvie and Simcere enter a $1B T-cell engager deal

In monkeys, enhanced TB vaccine dissolves after inducing protection

New drugs with the same old resistance tricks?

Dermatologic RSS

Dermatologic
RSS